Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Surgery and Opioids: Changing the perioperative patient experience and expectation


News provided by

Pennsylvania Medical Society

Jun 01, 2016, 08:05 ET

Share this article

Share toX

Share this article

Share toX

HARRISBURG, Pa., June 1, 2016 /PRNewswire-USNewswire/ -- Should patients expect their doctor to write an opioid prescription when recovering from surgery?

In recent years, they have.  Studies show that not only are patients going home with a prescription for drugs like oxycodone, but they're also filling those prescriptions at a high rate.

A report published in the Journal of the American Medical Association (JAMA) in March 2016 found that out of 14 million patients studied who underwent certain operations considered low-risk, 80 percent filled a prescription within seven days for any opioid.  The overwhelming majority – 86 percent – of these prescriptions were for hydrocodone/acetaminophen or oxycodone/acetaminophen.

Another study also published in JAMA during March 2016 involved more than 2.7 million Medicaid subscribers who had a tooth removed. That study found 42 percent filled a prescription for an opioid within seven days.

"Pretty clearly, opioids after surgery have become a routine of postoperative pain management," says Scott Shapiro, MD, president of the Pennsylvania Medical Society.  "However, with worries rising about the addictive nature of certain pain relievers and pressure building to address an overreliance on such medications, the days of this type of prescribing are numbered."

Dr. Shapiro says as prescribing practices change, patient expectations and thus patient satisfaction when recovering from surgery will need to be nurtured as other options are tried.

Opioids Explode Onto The Scene

Although Americans make up only 4.6 percent of the world population, they consume 80 percent of global opioid supply.  That figure increases to 99 percent when looking at hydrocodone.

From 1997 to 2007, retail sales of commonly used opioid medications jumped from 50.7 million grams to 126.5 million grams.

With such increase, it should come as no surprise that the number of people who admitted to abusing painkillers also increased. One study suggests that between 1992 and 2003, there was a 90 percent surge in abuse.

"Emergency departments often see the end-result of opioid abuse," says Merle Carter, MD, FACEP, president of the Pennsylvania College of Emergency Physicians who practices medicine in Philadelphia. "Certainly over my career, I've seen too many individuals end up in my emergency rooms who have overdosed."

In mid-February 2016, Modern Healthcare took a closer look at the root of the country's opioid abuse problem and traced it back to 1996 when Purdue Pharma began promoting a new drug to fight pain – OxyContin. Early on, the medication was billed as being safe because it would slowly release narcotic ingredients, making it unlikely to become addictive.

"We were told that this new drug would be the answer to many issues related to pain, particularly since a year earlier pain became the fifth vital sign and the American Pain Society recommended it be added to the indicators that assess overall health," says Bradley Levin, MD, FACC, FACS, FASAM, DABAM, CMRO of York County Medical Society who is also a member of the York County Heroin Task Force. According to Dr. Levin, there was even a time when physicians would be penalized for not prescribing opioids.

Nearly 10 years later in 2007 Purdue would plead guilty in federal court to criminal charges that they misled regulators, doctors, and patients about the drug's risk of addiction as well as its potential to be abused.

"We know better today, but the beast was unleashed and as addictions grew so did doctor shopping and other illegal activities," says Dr. Levin. "Those seeking pills got really good at finding what they wanted and in some cases pushed the drug out onto the street."

Post-surgery: If not opioids, what?

While opioids have been the primary treatment for pain while recovering from surgery, side effects and adverse reactions are possible, and they're being addressed by both physicians and patients.

"Opioids can cause nausea, confusion, vomiting, constipation, and respiratory depression as well as the risk of abuse," says Patrick Smith, MD, vice president of the Pennsylvania Orthopaedic Society (POS).  "Orthopaedic surgeons are implementing multimodal protocols in the pre-surgery period as a means to reduce patient pain, shorten the recovery period and avoid opioid use."

According to Dr. Smith, who is chair of the POS Opioid Task Force, orthopaedic surgeons begin post-operative pain reduction modalities at least one week prior to surgery.  Total knee replacement is a prime example.  In the past, this procedure required hospitalization for almost a week in addition to several weeks of post-surgery opioid pain medication. Today's multimodal approach allows patients to take fewer narcotics and spend only a day or two in a facility. 

The Enhanced Recovery After Surgery (ERAS) protocol begins at least one week prior to surgery with a diet rich in carbohydrates and protein as well as hydration with sports drinks.  On surgery day, a patient receives oral medications designed to reduce pain by working in several different ways: an anti-inflammatory medication reduces swelling; a neuro-modulating medication blocks pain receptors; and a long acting narcotic reduces actual pain. In addition, an adductor canal catheter is inserted preoperatively and connected to a pump for up to 48 hours of post-operative pain control.

The ERAS protocol further enhances pain management by intraoperative injection of the knee capsule with a mixture of bupivacaine with epinephrine and ketorolac.  Post-operatively, the anti-inflammatory, neuro-modulating and narcotic medications are continued. 

Using this multimodal technique, post-operative pain is controlled well enough to allow the patient to ambulate in physical therapy within a few hours of surgery and to leave the hospital setting within a day or two.  The patient may still require oral narcotic analgesics in the early post-op period, but narcotics are quickly weaned and the patient is transferred to non-narcotic medications typically by six weeks post-op.

"Orthopaedic surgeons across the country regularly perform procedures that make a difference in a person's life, but comes with some degree of pain while recovering," he says.  "With the ERAS, we are partnering with our patients to reduce post-operative pain and to quickly return them to their active lives."  

Mackenzie Moran of Carlisle, Pa., is a lacrosse player at Baldwin Wallace University in Ohio, who early in the 2016 season tore both her ACL and meniscus. She's also a patient whose doctors used a combination of therapies – before, during, and after surgery – to address pain.

Hours after her surgery she was home resting, and within days back in classes at Baldwin Wallace.

"Recovery isn't fun, and some pain was part of my experience," she says. "Between my team doctor from the Cleveland Clinic, athletic trainers at Baldwin Wallace, my surgeon at Penn State, and a physical therapist in my hometown, I had a plan that included a variety of ways to ease my pain ranging from a nerve block to ice.  I really only used Percocet for a short time and everyone encouraged me to minimalize using it."

'Be Smart. Be Safe. Be Sure.' Launches

Back at the Pennsylvania Medical Society, Dr. Shapiro sees a need for greater patient empowerment as part of the solution to the country's opioid crisis. 

"It's as much a part of the answer as physician education, prescribing guidelines, and opioid tracking," he says. "Patients will see prescribing patterns change and alternative options tried to reduce opioid use. That's going to be the new expectation instead of relying so heavily on opioids."

As such, Dr. Shapiro's organization launched a patient empowerment advocacy program in May titled "Opioids for Pain: Be Smart. Be Safe. Be Sure."

According to Dr. Shapiro, the initiative will educate the public through physician offices and state politicians who offer health and senior fairs. Social media will also be tapped.

"Patients in pain deserve care and compassion," says Dr. Shapiro. "Treating pain is among the most difficult – and most common – reasons patients come to us."

"As physicians, we are often under pressure to 'satisfy a patient's pain' and sometimes this requires prescribing an opioid," he says. "But caring also means sometimes saying no and recommending an alternative course of treatment – no matter how difficult that may be."

Dr. Shapiro says the initiative will encourage patients to ask their doctors several important questions when a prescription is written. Questions include

  1. Is this prescription an opioid?
  2. At what level of pain should I take this prescription?
  3. Do I have to take every pill in the prescription?
  4. Where can I safely dispose of remaining pills?
  5. What can I do to avoid addiction?
  6. What are possible warning signs of dependence or addiction?
  7. What can I do if I believe that I might have developed a dependence on this drug?

"Ultimately, when it comes to opioid use, patients and their doctors need to be smart; they need to be safe; and they need to be sure," says Dr. Shapiro. "That's our key message."

A copy of the initiative's logo is available for download at www.pamedsoc.org/opioidinfo.

This news release is brought to you by the Pennsylvania Health News Service Project, consisting of 21 Pennsylvania-based medical and specialty associations and societies. Members of PHNS include Pennsylvania Allergy & Asthma Association, Pennsylvania Dental Association, Pennsylvania Academy of Dermatology & Dermatologic Surgery, Pennsylvania Academy of Ophthalmology, Pennsylvania Academy of Otolaryngology, Pennsylvania Academy of Family Physicians, Pennsylvania American Congress of Obstetricians and Gynecologists, Pennsylvania Chapter of the American College of Cardiology, Pennsylvania Chapter of the American College of Emergency Physicians, Pennsylvania Chapter of the American College of Physicians, Pennsylvania Chapter of the American Academy of Pediatrics, Pennsylvania Medical Society Alliance, Pennsylvania Medical Society, Pennsylvania Neurosurgical Society, Pennsylvania Orthopaedic Society, Pennsylvania Psychiatric Society, Pennsylvania Society of Anesthesiologists, Pennsylvania Society of Gastroenterology, Pennsylvania Society of Oncology & Hematology, Robert H. Ivy Society of Plastic Surgeons, and Urological Association of Pennsylvania. Inquiries about PHNS can be directed to Chuck Moran via the Pennsylvania Medical Society at (717) 558-7820, [email protected], or via Twitter @ChuckMoran7.

SOURCE Pennsylvania Medical Society

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.